Adma Biologics (ADMA) Free Cash Flow (2011 - 2025)
Adma Biologics (ADMA) posted Free Cash Flow of $34.6 million for Q4 2025, up 3314.42% on a QoQ basis from -$1.1 million in Q3 2025, and down 27.19% year-over-year from $47.5 million in Q4 2024.
Adma Biologics (ADMA) Free Cash Flow (2011 - 2025) Analysis & Trends
Adma Biologics' Free Cash Flow history runs 13 years deep, the most recent figure standing at $34.6 million for Q4 2025.
- Quarterly Free Cash Flow fell 27.19% year-over-year to $34.6 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $27.8 million (down 74.81% YoY) and the FY2025 annual result came in at $27.8 million, down 74.81% from the prior year.
- Free Cash Flow was $34.6 million for Q4 2025 at Adma Biologics, up from -$1.1 million in the prior quarter.
- Across five years, Free Cash Flow topped out at $47.5 million in Q4 2024 and bottomed at -$37.1 million in Q4 2021.
- A 5-year average of -$2.9 million and a median of -$9.0 million in 2022 frame the typical range for Free Cash Flow.
- Annual changes were most pronounced in 2024 — Free Cash Flow soared 728.77% — and 2025, when it tumbled 433.98%.
- Adma Biologics' Free Cash Flow stood at -$37.1 million in 2021, then soared by 70.04% to -$11.1 million in 2022, then surged by 247.38% to $16.4 million in 2023, then soared by 189.38% to $47.5 million in 2024, then slipped by 27.19% to $34.6 million in 2025.
- Business Quant data shows ADMA's Free Cash Flow at $34.6 million in Q4 2025, -$1.1 million in Q3 2025, and $18.7 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -19.58 Mn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -2.49 Mn |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 158.09 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 1.29 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 848.30 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -354.95 Mn |
| 10 | Adma Biologics | 1.98 Bn | 1.89 Bn | 88.82 Mn | 34.56 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 34.56 Mn |
| Dec 31, 2025 | 34.56 Mn |
| Sep 30, 2025 | -1.08 Mn |
| Sep 30, 2025 | -1.08 Mn |
| Jun 30, 2025 | 18.72 Mn |
| Jun 30, 2025 | 18.72 Mn |
| Mar 31, 2025 | -24.38 Mn |
| Mar 31, 2025 | -24.38 Mn |
| Dec 31, 2024 | 47.46 Mn |
| Dec 31, 2024 | 47.46 Mn |
| Sep 30, 2024 | 23.97 Mn |
| Sep 30, 2024 | 23.97 Mn |
| Jun 30, 2024 | 43.58 Mn |
| Jun 30, 2024 | 43.58 Mn |
| Mar 31, 2024 | -4.57 Mn |
| Mar 31, 2024 | -4.57 Mn |
| Dec 31, 2023 | 16.40 Mn |
| Dec 31, 2023 | 16.40 Mn |
| Sep 30, 2023 | 11.23 Mn |
| Sep 30, 2023 | 11.23 Mn |